Neuropharmacology of venlafaxine

Depress Anxiety. 2000:12 Suppl 1:20-9. doi: 10.1002/1520-6394(2000)12:1+<20::AID-DA3>3.0.CO;2-M.

Abstract

Venlafaxine (Effexor) is an effective antidepressant and has also been approved for the treatment of generalized anxiety disorder. Venlafaxine was initially characterized as an inhibitor of both serotonin (5HT) and norepinephrine (NE) uptake and was therefore termed a "dual uptake inhibitor." This chapter reviews data from both in vitro and in vivo studies regarding its effects on 5HT and NE neurotransmission. In addition, the effects of venlafaxine on other systems that may play a role in its therapeutic efficacy effects are described. The data indicate that venlafaxine is a relatively weak inhibitor of NE transport in vitro. In vivo studies indicate that venlafaxine selectively inhibits 5HT uptake at low therapeutic doses and inhibits both 5HT and NE uptake at higher therapeutic doses. This chapter concludes with a discussion of the effects of venlafaxine on various aspects of physiology.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adenylyl Cyclases / metabolism
  • Anxiety Disorders / drug therapy
  • Corticotropin-Releasing Hormone / drug effects
  • Cyclohexanols / pharmacology*
  • Cyclohexanols / therapeutic use
  • Electroencephalography
  • Humans
  • Locus Coeruleus / drug effects
  • Locus Coeruleus / physiology
  • Raphe Nuclei / drug effects
  • Raphe Nuclei / physiology
  • Receptors, Adrenergic, beta / drug effects
  • Receptors, Adrenergic, beta / metabolism
  • Selective Serotonin Reuptake Inhibitors / pharmacology*
  • Selective Serotonin Reuptake Inhibitors / therapeutic use
  • Sleep, REM / drug effects
  • Synaptic Transmission / drug effects
  • Venlafaxine Hydrochloride

Substances

  • Cyclohexanols
  • Receptors, Adrenergic, beta
  • Serotonin Uptake Inhibitors
  • Venlafaxine Hydrochloride
  • Corticotropin-Releasing Hormone
  • Adenylyl Cyclases